PRL and myeloid sarcoma: The concept of low circulating PRL levels as a clinical syndrome appeared for the first time in 2009 (Corona et al., 2009) in association with sexual dysfunction in which male patients with PRL serum levels b5 μg/L showed a higher risk of MS (Macotela et al., 2020; Corona et al., 2009).